Your Article Summary
See Latest ArticlesHypogonadotropic Hypogonadism in Men with Type 2 Diabetes
Postgraduate Medicine, 06/03/09
Dandona P et al. - It has recently been demonstrated that >= one-third of men with type 2 diabetes mellitus have low testosterone concentrations associated with inappropriately low luteinizing hormone and follicle-stimulating hormone concentrations. Hypogonadotropic hypogonadism in men with type 2 diabetes is associated with obesity but not duration of diabetes, elevated glycosylated hemoglobin, or the presence of microvascular complications of diabetes. Recent data show that hypogonadotropic hypogonadism is also observed frequently in nondiabetics with the metabolic syndrome or obesity, but it is not associated with type 1 diabetes. Low testosterone concentrations in men with type 2 diabetes have also been related to a higher C-reactive protein concentrations, lower hematocrit, increased total and regional adiposity, lower bone mineral density, and erectile dysfunction. This article discusses the pathophysiology of hypogonadotropic hypogonadism in men with type 2 diabetes and its signs and symptoms. Clinical trials are required to determine whether testosterone replacement therapy alleviates insulin resistance, infl ammation, and symptoms related to sexual dysfunction care.
Related Articles
Impaired Fibroblast Growth Factor Receptor 1 Signaling as a Cause of Normosmic Idiopathic Hypogonadotropic Hypogonadism
Journal of Clinical Endocrinology and Metabolism, 10/15/09
Relevance Score: 65%
Pregnancy and beta-thalassemia: an Italian multicenter experience
Haematologica, 11/16/09
Relevance Score: 64%
X-Linked Congenital Adrenal Hypoplasia with Hypogonadotropic Hypogonadism Caused by an Inversion Disrupting a Conserved Noncoding Element Upstream of the NR0B1 (DAX1) Gene
Journal of Clinical Endocrinology and Metabolism, 10/07/09
Relevance Score: 64%
Hypogonadism Risk in Men Treated for Childhood Cancer
Internet Source, 11/05/09
Relevance Score: 45%
Hypogonadism Risk in Men Treated for Childhood Cancer
Journal of Clinical Endocrinology and Metabolism, 10/12/09
Relevance Score: 44%
Today in Endocrine...keeping you current
Receive free subspecialty "5-minute updates" via email
A new FSHbeta mutation in a 29 year-old woman with primary amenorrhea and isolated FSH deficiency: functional characterization and ovarian response to human recombinant FSH
European Journal of Endocrinology, 12/17/09
Lower urinary tract symptoms, obesity and the metabolic syndrome
Current Opinion in Urology, 12/09/09
Kisspeptin/GPR54 system as potential target for endocrine disruption of reproductive development and function
International Journal of Andrology, 11/13/09